Developmental Research Program

发展研究计划

• 批准号: 10683763
• 负责人: Walter J. Storkus
• 金额: $ 9.06万
• 依托单位: UNIVERSITY OF PITTSBURGH AT PITTSBURGH
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-08-15 至 2026-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10683763
• 关键词: Advocate; Applications Grants; Area; Award; Basic Science; Biological Response Modifier Therapy; Cancer Center; Clinic; Clinical; Clinical Research; Collaborations; Communities; Comprehensive Cancer Center; Data; Development; Eligibility Determination; Extramural Activities; Feedback; Funding; Future; Goals; Grant; Immunotherapy; Institution; International; Mentors; Ohio; Patients; Peer Review; Pilot Projects; Preparation; Process; Program Research Project Grants; Publications; Research; Research Personnel; Research Support; Resources; Roswell Park Cancer Institute; Services; Skin Cancer; Source; System; Time; Translational Research; Translations; United States National Institutes of Health; Universities; broadening participation research; cancer therapy; high reward; high risk; innovation; meetings; melanoma; member; novel; programs; recruit; symposium; working group

ABSTRACT: Developmental Research Program (DRP) The MSCP SPORE Developmental Research Program (DRP) provides seed funding to explore promising novel research in melanoma and other skin cancers, particularly by investigators not currently engaged in research in this area. The DRP will solicit proposals 1-2 times per year and applies a peer-reviewed scoring system to prioritize the funding of 2-3 proposals per year at up to $75K/proposal/year. The DRP and SPORE Co-Directors, Regional Melanoma Consortium (RMC) representatives, and members of our SPORE Internal Advisory Board (IAB) and External Advisory Board (EAB) participate in the review process, together with Patient Advocates and any additional experts necessary to judge project feasibility, translational significance and likely overall impact. During the most recent period of funding, the MSCP SPORE supported 9 DRP projects in basic, translational, and clinical research. The DRP Co-Directors track the progress of the successful applications and assign mentors to funded investigators to ensure that they obtain any needed services from the MSCP SPORE Cores, and that they are effectively integrated into the SPORE program. Awardees present their research results to the MSCP SPORE membership after one year of funding to become eligible for a second year of support. Progress toward translation as well as impact and innovation will determine whether DRP projects are found to merit promotion to full SPORE projects at the time of formulating a renewal bid. Awardees are also advised as appropriate in the preparation of grant applications for funding outside the SPORE mechanism and given access to all SPORE Core resources to aid in this endeavor. DRP- supported research over the most recent period of support resulted in funded NIH R01, R21 and P01 grants, numerous publications and presentations at local, national and international meetings/symposia that serve to enhance MSC SPORE visibility on a global level.

摘要：发展研究计划（DRP） MSCP孢子发展研究计划（DRP）提供种子资金，以探索有前途的 黑色素瘤和其他皮肤癌的新研究，特别是目前没有参与的研究人员， 在这个领域的研究。DRP每年将征求1-2次提案，并采用同行评审评分 该系统每年优先资助2-3个提案，最高可达7.5万美元/提案/年。DRP和SPORE 联合董事，区域黑色素瘤联盟（RMC）代表，以及我们的SPORE内部成员 咨询委员会（IAB）和外部咨询委员会（EAB）参与审查过程， 患者权益倡导者和判断项目可行性、转化意义所需的任何其他专家 可能的整体影响。在最近一段时间的资金，MSCP SPORE支持9 DRP 基础、转化和临床研究项目。DRP联合主任跟踪 成功的申请，并为受资助的调查人员指派导师，以确保他们获得任何所需的 服务，并将其有效地集成到SPORE计划中。 获奖者在一年的资助后向MSCP SPORE会员展示他们的研究成果， 有资格获得第二年的支持。翻译以及影响和创新方面的进展将 在制定时确定DRP项目是否值得提升为完整的SPORE项目 续约的出价此外，我们亦会在适当时候向得奖者提供意见，协助他们拟备拨款申请 在SPORE机制之外，并被给予访问所有SPORE核心资源的权限，以帮助完成这项奋进。DRP- 在最近的支持期内，支持的研究导致了NIH R 01，R21和P01赠款的资助， 在地方、国家和国际会议/专题讨论会上发表了大量出版物和演讲， 增强MSC SPORE在全球范围内的知名度。